Intelerad just got a whole lot bigger, acquiring Ambra Health to create one of the industry’s most comprehensive image management companies.
Acquisition Details – The acquisition values the combined companies at $1.7b, expands their reach to nearly 2k global customers (including all of the US’ top 10 hospitals), and brings their headcount to roughly 1k team members. Ambra CEO, Morris Panner, will become Intelerad’s president and will lead the company alongside CEO, Mike Lipps.
Intelerad + Ambra Portfolio – The acquisition combines Intelerad’s PACS portfolio with Ambra’s cloud VNA, image exchange, custom integration services, and research and pathology capabilities.
Competitive Impact – At least in terms of portfolio breadth, this acquisition moves Intelerad into enterprise imaging’s top tier (radiology, cardiology, archive, sharing), helping it expand beyond its radiology practice legacy and deeper into hospitals. However, the star of this acquisition may prove to be combining Ambra’s cloud VNA with Intelerad’s cloud PACS, which as we’ve seen from Visage and Change’s recent cloud takeovers, can be a very effective combination.
Intelerad Growth – Intelerad has taken full advantage of its PE-backing, making a series of acquisitions since mid-2020 that allowed expansions into new specialties (cardiac & OB/GYN), regions (UK), and technologies (cloud). Ambra is clearly its biggest investment and most significant expansion yet.